.png)
Last Friday, Sept 10th, 2021, the Clinical Research Organization (CRO) in charge of managing the clinical trial for RUTI therapeutic vaccine in India, made sure the All India Institute of Medical Sciences (AIMMS) personnel and facilities are ready to start enrolling tuberculosis patients in the clinical trial. The CRO confirms that the vaccine is ready on site and all the source documents and regulatory documents are completed; the first patient should be enrolled by the end of September.
Comentarios